[Federal Register Volume 72, Number 48 (Tuesday, March 13, 2007)]
[Notices]
[Pages 11363-11364]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-4533]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Thrombosis and Hemostasis Centers Research and 
Prevention Network, Request for Applications (RFA) DD07-004 and RFA 
DD07-005

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
SEP:

    Time and Date: 12 p.m.-4 p.m., May 3, 2007 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of scientific merit of grant applications 
received in response to RFAs DD07-004 and DD07-005, ``Thrombosis and 
Hemostasis Centers Research and Prevention Network.''

[[Page 11364]]

    For Further Information Contact: Christine Morrison, Ph.D., 
Scientific Review Administrator, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE., Mailstop D72, Atlanta, GA 30333, 
Telephone 404.639.3098.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-4533 Filed 3-12-07; 8:45 am]
BILLING CODE 4163-18-P